1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

09Jan/12

New Urine Test Identifies Acute Kidney Injury – Renal Business Today

January 9, 2012Organ Failureadmin

New Urine Test Identifies Acute Kidney InjuryRenal Business TodayNEW YORK— Researchers have discovered a new way to diagnose Acute Kidney Injury (AKI) using a urine test enabling emergency departments to identify high-risk patients upon arrival, acco…

09Jan/12

Biogen Idec Presents 2012 Strategic Priorities at 30th Annual J.P. Morgan … – Business Wire (press release)

January 9, 2012Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Biogen Idec Presents 2012 Strategic Priorities at 30th Annual J.P. Morgan …Business Wire (press release)Continuing to advance the daclizumab Phase 3 program in MS. Building world-class scientific teams in its core therapeutic areas. Advancing the com…

09Jan/12

Biogen Idec presenta le priorità strategiche per il 2012 in occasione della … – Business Wire (Comunicati Stampa)

January 9, 2012Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Biogen Idec presenta le priorità strategiche per il 2012 in occasione della …Business Wire (Comunicati Stampa)… lancio ea richieste normative successivi. realizzazione del programma di fase 3 per il daclizumab nella SM. approfondimento delle colla…

09Jan/12

Biogen Idec stellt auf der 30. Annual J.P. Morgan Healthcare Conference … – Business Wire (Pressemitteilung)

January 9, 2012Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Biogen Idec stellt auf der 30. Annual J.P. Morgan Healthcare Conference …Business Wire (Pressemitteilung)Weitere Fortentwicklung des Programms Phase 3 mit Daclizumab bei MS. Bildung von Wissenschaftlerteams von Weltklasse in den therapeutischen Kernb…

09Jan/12

Organ donor recipient an inspiration – Bega District News

January 9, 2012Organ Donoradmin

Organ donor recipient an inspirationBega District NewsMr Rossiter now leads a full life with his wife and son, and with his experiences and understanding established the Eurobodalla Renal Support Group and Organ Donor Awareness. To hear more of Mr Ross…

09Jan/12

Small Dose of Rituximab for Graves Orbitopathy: New Insights Into the … – Archives of Ophthalmology

January 9, 2012Immunosuppressive Drugsadmin

Small Dose of Rituximab for Graves Orbitopathy: New Insights Into the …Archives of OphthalmologyPatients with GO underwent rituximab infusion after premedication with acetaminophen, chlorpheniramine maleate, and 100 mg of hydrocortisone sodium succin…

09Jan/12

This Month in Archives of Neurology – Archives of Neurology

January 9, 2012Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

This Month in Archives of NeurologyArchives of NeurologyGorman et al (SEE ARTICLE) report the use of daclizumab in pediatric-onset multiple sclerosis (POMS). They find that daclizumab may be a safe and at least partially effective treatment option for …

09Jan/12

The Transitionalist: Optimizing Inpatient-to-Outpatient Transitions of Care – Archives of Internal Medicine

January 9, 2012Organ Failureadmin

The Transitionalist: Optimizing Inpatient-to-Outpatient Transitions of CareArchives of Internal MedicineI read the recent article on the implementation of a transitional care program (TCP) for patients with heart failure at Baylor Medical Center Garlan…

09Jan/12

CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-9 Afternoon – Beacon Equity Research

January 9, 2012Transplant Rejectionadmin

CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-9 AfternoonBeacon Equity ResearchTheir market cap is 13.82B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-thr…

09Jan/12

Investigational RCC agent improves progression-free survival – ModernMedicine

January 9, 2012Transplant Surgeryadmin

Investigational RCC agent improves progression-free survivalModernMedicineAll 517 patients in the study had clear cell RCC, had undergone a prior nephrectomy, and had not previously been treated with either a vascular endothelial growth factor or mamma…

Posts navigation

  • « Previous
  • 1
  • …
  • 17,851
  • 17,852
  • 17,853
  • 17,854
  • 17,855
  • …
  • 18,183
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos